• 1. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 2. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 3. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
• 4. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 5. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita

• Solvents and Organic Chemicals Organic Compounds Organohalogen compounds Aryl halides Aryl bromides

Professional Introduction to 3-Bromo-5-hydroxymethylisoxazole (CAS No. 25742-00-1)

3-Bromo-5-hydroxymethylisoxazole, with the chemical formula C?H?BrN?O? and CAS number 25742-00-1, is a significant compound in the field of pharmaceutical chemistry and bioorganic synthesis. This heterocyclic aromatic compound has garnered considerable attention due to its versatile structural framework and potential applications in drug development. The presence of both bromine and hydroxymethyl substituents on the isoxazole ring endows it with unique reactivity, making it a valuable intermediate in the synthesis of more complex molecules.

The isoxazole core is a prominent scaffold in medicinal chemistry, known for its role in various bioactive compounds. Its five-membered ring contains two nitrogen atoms, which contribute to its ability to interact with biological targets in multiple ways. The 3-bromo substitution at the third position of the ring introduces a reactive site that is highly conducive to further functionalization via cross-coupling reactions, such as Suzuki-Miyaura or Buchwald-Hartwig couplings. These reactions are pivotal in constructing carbon-carbon bonds, a fundamental requirement in the assembly of complex pharmaceuticals.

The 5-hydroxymethyl group at the fifth position adds another layer of reactivity, enabling oxidation or reduction processes that can lead to diverse derivatives. This dual functionality makes 3-Bromo-5-hydroxymethylisoxazole an excellent building block for exploring new pharmacophores. Recent advancements in synthetic methodologies have highlighted its utility in generating novel analogs for therapeutic applications. For instance, researchers have leveraged this compound to develop inhibitors targeting enzymes involved in inflammatory pathways, showcasing its potential in addressing chronic diseases.

In the realm of drug discovery, the compound's structural features align well with modern trends toward targeted therapies. The bromine atom facilitates palladium-catalyzed reactions, allowing for precise modifications at specific positions on the isoxazole ring. This precision is crucial for optimizing drug-like properties such as solubility, bioavailability, and metabolic stability. Moreover, the hydroxymethyl group can be further elaborated into ether or ester functionalities, expanding the chemical space available for designing next-generation therapeutics.

Recent studies have demonstrated the compound's role in developing small-molecule probes for biochemical assays. By incorporating fluorescent or luminescent tags through post-synthetic modifications, researchers can investigate enzyme mechanisms and protein interactions with high sensitivity. Such probes are indispensable tools in drug discovery pipelines, enabling rapid screening of potential candidates. The adaptability of 3-Bromo-5-hydroxymethylisoxazole in these applications underscores its importance as a versatile intermediate.

The synthesis of 3-Bromo-5-hydroxymethylisoxazole typically involves multi-step processes that begin with readily available precursors. Common synthetic routes include halogenation of hydroxymethylisoxazole derivatives followed by functional group transformations to introduce the bromine atom at the desired position. Advances in catalytic systems have improved yields and reduced byproduct formation, making large-scale production more feasible. These improvements align with broader industry trends toward greener and more efficient synthetic methodologies.

The compound's relevance extends beyond academic research into industrial applications. Pharmaceutical companies are increasingly exploring libraries of heterocyclic compounds like 3-Bromo-5-hydroxymethylisoxazole to identify novel drug candidates. Its structural motifs are often mimicked or modified to enhance pharmacological activity while minimizing side effects. This approach exemplifies how foundational intermediates contribute to the iterative process of drug development.

In conclusion, 3-Bromo-5-hydroxymethylisoxazole (CAS No. 25742-00-1) represents a cornerstone in modern pharmaceutical chemistry. Its unique structural features and reactivity make it indispensable for constructing complex molecules with therapeutic potential. As research continues to uncover new applications and synthetic strategies, this compound will remain a critical component in the quest for innovative treatments across various medical disciplines.

• 105174-96-7(1-(3-Bromo-isoxazol-5-YL)-ethanol)
• 76596-55-9(2-bromo-1-(3-bromo-1,2-oxazol-5-yl)ethan-1-ol)
• 25741-97-3(3-Bromo-5-methylisoxazole)
• 1220521-36-7(3-Bromo-5-(methoxymethyl)isoxazole)
• 153124-36-8(5-Isoxazolemethanol, 3-bromo-4-methyl-)
• 6567-35-7(3-Bromoisoxazole-5-carboxylic acid)
• 105175-00-6(3-Bromo-5-isoxazoleethanol)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)